Puma Biotechnology Soars On Phase III Data; Analyst Smells Takeover Candidate
July 23, 2014 at 11:51 AM EDT
Puma Biotechnology (NYSE: PBYI) has nearly tripled in value Wednesday on positive trial data for its lead breast cancer drug, while ...
